Funded Tech Companies
Tvardi Therapeutics
Wondering who backed Tvardi Therapeutics? Sporos Bioventures, 683 Capital and Slate Path Capital joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Tvardi Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2450 Holcombe Blvd. X
Houston, TX 77021
USA
Houston, TX 77021
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
Tvardi Therapeutics is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases. Founded in 2017 and based in Houston, Texas, the company is led by experienced entrepreneurs, innovative scientists and dedicated physicians.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/24/2021
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Imran Alibhai
Chief Scientific Officer
Jeno Gyuris
VP - Bus. Development
Sofia de Achaval
VP - R & D
Jeffrey Larson
Company Investors
- Sporos Bioventures
- 683 Capital
- Slate Path Capital (Jamie McNab)
- Palkon Capital Management
- ArrowMark Partners
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs